Management of herpetic eye disease.
We define in this paper a rational approach to the management of the various stages of herpetic eye disease. We consider in more detail comparisons between idoxuridine (IDU), trifluorothymidine (F3T), and adenine arabinoside (Ara-a) (derived largely from clinical trials in herpetic ulcers). We discuss metaherpetic ulcers and certain aspects of keratoplasty.
D000328:Adult; D000368:Aged; D016039:Corneal Transplantation; D005260:Female; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007635:Keratitis, Dendritic / Q000188:drug therapy* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012008:Recurrence; D014271:Trifluridine / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use
D014740:Vidarabine; D007065:Idoxuridine; D014271:Trifluridine